SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

UBS Maintains Sell on NuVasive, Lowers Price Target to $55

UBS maintains NuVasive (NASDAQ:NUVA) with a Sell and lowers the price target from $65 to $55.

Benzinga · 05/07/2020 16:32

UBS maintains NuVasive (NASDAQ:NUVA) with a Sell and lowers the price target from $65 to $55.